Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Cash flows from operating activities:          
Net loss from continuing operations $ (499,841) $ (1,490,097) $ (2,765,973) $ (5,157,425)  
Adjustments to reconcile net loss to net cash (used in) provided by operations:          
Depreciation and amortization 117,216 193,640 234,040 378,864  
Loss on disposition of property and equipment     858  
Amortization of debt discount     27,630  
Net loss (gain) from legal settlements 76,218 (31,050) 76,218 (22,190)  
Other income from federal government provider relief funds     (4,400,000)  
Gain on extinguishment of PPP Notes     (334,819)  
Gain on sale of discontinued operations (10,727,152) (10,727,152)  
(Loss) income from discontinued operations     (5,379) 10,334,749  
Changes in operating assets and liabilities:          
Accounts receivable, net     186,131 920,577  
Inventory     36,890 (45,573)  
Prepaid expenses and other current assets     21,304 (26,640)  
Security deposits     (10,000) (18,542)  
Change in right-of-use assets     117,871 89,731  
Accounts payable and checks issued in excess of bank balances     484,458 1,837,074  
Accrued expenses     867,828 3,126,033  
Change in right-of-use operating lease obligations     (117,871) (89,731)  
Net cash used in operating activities of continuing operations     (1,208,444) (3,772,595)  
Net cash (used in) provided by operating activities of discontinued operations     (1,714) 40,098  
Net cash used in operating activities     (1,210,158) (3,732,497)  
Cash flows from investing activities:          
Receivable from related party     (428,943)  
Purchases of property and equipment     (33,940) (80,132)  
Net cash used in investing activities of continuing operations     (462,883) (80,132)  
Cash flows from financing activities:          
Proceeds from issuance of related party loan payable and advances     750,000 890,000  
Payment on related party loan payable and advances     (360,000)  
Proceeds from issuances of notes payable     1,245,000  
Payments on notes payable     (1,171,603) (100,508)  
Receivables paid under accounts receivable sales agreements     (317,647) (247,986)  
Proceeds from issuances of preferred stock     1,500,000 2,500,000  
Proceeds from HHS Provider Relief Funds     314,651  
Cash paid for fractional shares in connection with reverse stock split     (9)  
Net cash provided by financing activities of continuing operations     1,075,392 3,926,506  
Net cash provided by financing activities of discontinued operations     60,402  
Net cash provided by financing activities     1,075,392 3,986,908  
Net change in cash     (597,649) 174,279  
Cash at beginning of period     724,524 25,353 $ 25,353
Cash at end of period $ 126,875 $ 199,632 $ 126,875 $ 199,632 $ 724,524